PhRMA

New Report Shows Oregon Clinical Trials Benefit State’s Health and Economy

The Lund Report
Clinical trials of new medicines target the most debilitating chronic diseases

Working in collaboration with Oregon’s university medical schools, hospitals and clinical research centers, biopharmaceutical companies are conducting or have conducted since 1999 more than 2,300 clinical trials of new medicines in the state, a report released today shows.

Subscribe to PhRMA